TRNX yields 2000000.00% · JNJ yields 2.13%● Live data
📍 TRNX pulled ahead of the other in Year 1
Combined, TRNX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TRNX + JNJ for your $10,000?
Taronis Technologies, Inc., a technology-based company, focuses on addressing the constraints on natural resources primarily in the United States. The company offers MagneGas, a hydrogen-based synthetic fuel that is used as an alternative to acetylene and other natural gas derived fuels for metal cutting and other commercial uses. It also provides Plasma Arc Flow System for MagneGas production, or water decontamination and sterilization. In addition, the company sells and licenses its proprietary plasma arc technology for gasification and the processing of liquid waste. It distributes and sells MagneGas fuel, and other gases and welding supplies through retail locations. The company was formerly known as MagneGas Applied Technology Solutions, Inc. and changed its name to Taronis Technologies, Inc. in January 2019. Taronis Technologies, Inc. was founded in 2005 and is headquartered in Peoria, Arizona.
Full TRNX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.